More than $274,000 in NSF funding
to develop breakthrough aneurysm sac
management technology
COSTA MESA, Calif.,
July 15,
2024 /PRNewswire/ -- Life Seal Vascular
Inc. (www.lifesealvascular.com), a pioneering company
dedicated to revolutionizing endovascular treatment, is
thrilled to announce that it has been awarded the highly
competitive National Science Foundation (NSF) Small
Business Innovation Research (SBIR) grant.
This funding will accelerate the development of Life
Seal Vascular's cutting-edge technology to improve
patient outcomes and advance the field of endovascular aortic
repair (EVAR).
"We are honored to receive this prestigious SBIR
grant from the NSF. This funding is a
testament to the innovative potential of our technology and our commitment to advancing
EVAR care," said Bob Mitchell,
Executive Chairman of the Board at Life Seal Vascular Inc. "With
this support, we are well-positioned to advance the development of
our breakthrough aneurysm sealing solutions and make a significant
impact on the lives of EVAR patients worldwide."
The NSF SBIR grant will enable Life Seal Vascular
to further develop its proprietary aneurysmal sac
sealing technology. Designed as an adjunctive therapy to
native endografts, Life Seal Vascular's groundbreaking
approach seals the entire aneurysmal sac potentially eliminating
endoleaks, reducing reintervention rates and improving clinical
outcomes for EVAR patients.
Dr. Michel Reijnen, a renowned
vascular surgeon, commented on the significance of Life Seal
Vascular's technology, stating, "The advancements being made by
Life Seal Vascular are truly remarkable. Their
innovative solutions have the potential to revolutionize EVAR,
offering patients safer and more effective treatment options.
I am excited to see
the positive impact this technology will have on the field and on patient care."
The NSF SBIR program is a highly competitive
initiative that supports scientific excellence and technological
innovation through the investment of federal research funds. Life
Seal Vascular's selection for this grant underscores the company's
dedication to advancing medical technology and its potential to
deliver transformative healthcare solutions.
This grant is supported by
the U.S. National Science Foundation under
award number 2407378.
About Life Seal Vascular, Inc.
Life Seal Vascular Inc.
specializes in innovative sealing technologies for endovascular
repair of aortic aneurysms. Their proprietary solutions has the
potential to eliminate endoleaks,
the main cause of reinterventions in Endovascular
Aneurysm Repair (EVAR). By completely sealing the aneurysm, Life
Seal Vascular's devices ensure predictable
deployment and do not interfere with imaging, thereby
enhancing the effectiveness and safety of
endovascular repair procedures.
For more information about Life Seal Vascular Inc. and its groundbreaking technology,
please visit
[www.lifesealvascular.com](http://www.lifesealvascular.com).
About U.S. National Science Foundation Small Business
Program
America's Seed Fund powered by the U.S.
National Science Foundation Small Business programs focuses on
transforming scientific and engineering discoveries into products
and services with commercial and societal impact. The deep
technologies that are funded show promise, but their success hasn't
yet been validated. And, each year, the NSF awards $200+
million in research
and development (R&D) funding to about
400 startups across the United
States. America's Seed Fund is a program within the National
Science Foundation and housed within the Directorate for
Technology, Innovation and Partnerships.
Media Contact:
Bob Mitchell
Executive Chairman of the Board
Life Seal Vascular Inc.
Hannah Friend
602-618-3377
380385@email4pr.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/life-seal-vascular-inc-awarded-prestigious-nsf-sbir-grant-to-advance-innovative-endovascular-aortic-aneurysm-sac-management-technology-302196922.html
SOURCE Life Seal Vascular, Inc.